Urinary citrate excretion in healthy children depends on age and gender

Jan K Kirejczyk1, Tadeusz Porowski, Jerzy Konstantynowicz

  • 1Department of Pediatric Surgery, Medical University of Bialystok, Bialystok, Poland.

Insights

Urinary citrate excretion in children shows distinct sex differences at puberty, with girls excreting more citrate. Establishing reference values is crucial for assessing hypocitraturia, a risk factor for kidney stones.

Area of Science:

  • Pediatric Nephrology
  • Urology
  • Metabolic Disorders

Background:

  • Hypocitraturia is a significant risk factor for calcium nephrolithiasis.
  • A standardized reference database for pediatric urinary citrate excretion is lacking.
  • Understanding citrate excretion patterns in children is essential for stone prevention.

Purpose of the Study:

  • To establish 24-hour urinary citrate excretion levels in a large pediatric cohort.
  • To identify optimal units for expressing urinary citrate in children.
  • To investigate age- and sex-related variations in urinary citrate.

Main Methods:

  • Analyzed 24-hour urine samples from 2,334 healthy children (ages 2-18).
  • Assessed urinary citrate using an enzymatic method.
  • Expressed citrate levels in various units: absolute values, concentration, citrate/creatinine ratio, per kilogram body weight, per 1.73 m2 body surface area, and calcium/citrate index.

Main Results:

  • Citrate excretion increased with age until puberty, with girls showing significantly higher levels than boys post-puberty.
  • Urinary citrate, adjusted for creatinine and body weight, decreased with age in both sexes.
  • Recommended lower cut-off values for urinary citrate: 180 mg/1.73 m2/24 h for males and 250 mg/1.73 m2/24 h for females.

Conclusions:

  • Significant sex-dependent differences in urinary citrate emerge at puberty.
  • These findings highlight the need for sex-specific reference ranges for pediatric urinary citrate.
  • Further research is needed to determine if these differences impact urolithiasis risk in children.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
371
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
354
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
53
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa01:22

Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
915